S-phase fraction and breast cancer - a decade of experience
- 1 October 1998
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 51 (3) , 255-265
- https://doi.org/10.1023/a:1006188512927
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- Consensus review of the clinical utility of dna cytometry in carcinoma of the breastCytometry, 1993
- Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- The prognostic significance of nuclear DNA content in invasive breast cancer – a study with long-term follow-upBritish Journal of Cancer, 1989
- Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening programCancer, 1989
- Relationship between DNA ploidy and survival in patients with primary breast cancerBritish Journal of Surgery, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancerCancer, 1988
- DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimensCancer, 1988